Mirati Therapeutics Inc.

Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm’s products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.

Source link

You May Also Like

Previously sealed JFK assassination files released via an executive order signed by Biden

Prompted by an executive order signed by President Biden, The National Archives and…

How abortion bans are impacting pregnant patients across the country

Nine months after the Supreme Court overturned Roe v. Wade, ending nearly…

National Guard member who allegedly leaked classified docs spoke of “race war”: report

Jack Teixeira, the 21-year-old National Guardsman who is alleged to have leaked…

Kari Lake ally rages after Katie Hobbs is sworn in: “The legislature must vote to decertify”

Democrat Katie Hobbs on Monday was officially sworn in as Arizona’s governor,…